January 6, 2016 by Geoff Walden and Chain Drug Review
$4 generics, Chain Drug Review, health and wellness, Michelle Gloeckler, Pharmacy Innovator of the Year, retail pharmacy, Walmart, Walmart Care Clinics
2016, Featured Articles, Issue 01-04-2016, Issues, Leading Headlines, News, Pharmacy, Retail News
BENTONVILLE, Ark. — Walmart has had a long history of making health care more accessible and affordable. From the launch of $4 generics in 2006 to the recent introduction of Walmart Care Clinics, which promise to have the same kind of impact on pricing in that sector as the earlier program did in pharmacy, the
October 26, 2015 by Mark Baumgartner and Chain Drug Review
Fred’s Inc., Jerry Shore, John Foley, retail pharmacy, Walgreens
2015, Issue 10-26-2015, Issues, News
MEMPHIS — Fred’s Inc. has hired retail pharmacy veteran John Foley as executive vice president of store operations. Foley assumed his duties on October 7. He succeeded Mike Holligan, who was named to the open position of regional vice president of store operations for Fred’s. Foley is expected to help Fred’s continue to develop a
October 26, 2015 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, CVS Health, Jeffrey Woldt, medication adherence, MinuteClinic, Pharmacy Advisor, Predictive Adherence Index, retail pharmacy, ScriptSync, Vulnerable Patient Index, William Shrank
2015, Issue 10-26-2015, Issues, Leading Headlines, Opinion
The move toward closer cooperation among providers is one of the more intriguing developments in health care, one that promises to improve patient outcomes and limit expenditures in a sector that accounts for almost 20% of the nation’s gross domestic product. The rationale behind the partnerships, and the role of community pharmacies within them, is
October 13, 2015 by Chain Drug Review
Benzer Pharmacy, compounding pharmacies, retail pharmacy, specialty medications, specialty pharmacy
Leading Headlines, Retail News
TAMPA, Fla. — Benzer Pharmacy has set up shop in a new state, Georgia, with the official opening of a new drug store in Greensboro. Along with retail pharmacy services, the Greensboro store offers compounding and specialty medications. “Whereas the national chain drug stores offer virtually everything from soup to nuts, Benzer Pharmacy, an independent
September 8, 2015 by Venkat Rajan and Chain Drug Review
Frost & Sullivan, health care technologies, retail pharmacy, Venkat Rajan
Opinion
What if … in 2025 a 76-year-old Alzheimer’s patient, along with a family member, arrives at his local retail chain to test a newly launched augmented reality headset designed specifically for patients with cognitive disorders? The retailer helps with the fitting and initial customization of device parameters to suit the user’s needs. The headset will
May 1, 2015 by Chain Drug Review
CVS Health, first quarter, fiscal 2015, Larry Merlo, net income, net sales, PBM, pharmacy services, prescription count, retail pharmacy, same-store sales
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — Citing a strong performance by its pharmacy benefit management business, CVS Health posted a double-digit sales gain for the first quarter, with adjusted earnings topping Wall Street’s projections. CVS said Friday that net sales for the three months ended March 31 totaled $36.33 billion, up 11.1% from $32.69 billion a year earlier. Sales for CVS’ retail pharmacy business
February 2, 2015 by Jeffrey Woldt and Chain Drug Review
Bartell Drugs, Bartell family, Canadian operations, chain drug industry, CVS Health, Dollar Tree, Family Dollar, Fred's, Jeffrey Woldt, Mike Bloom, NACDS, National Association of Chain Drug Stores, RediClinic, retail pharmacy, Rite Aid, RxImpact Day, Target, Walgreens Boots Alliance, Walmart
2015, Issue 02-02-2015, Opinion
The new year is just over a month old and already the chain drug industry has seen its fair share of noteworthy events. Walgreens Boots Alliance had a coming out party, opening trading at NASDAQ and unveiling its new corporate logo; Brian Unmacht became the first person outside the Bartell family to serve as president
January 5, 2015 by Chain Drug Review and Chain Drug Review
chain drug industry, chain drug retailers, retail health care, retail pharmacy
2015, Business, Issue 01-05-2015, News, Pharmacy
NEW YORK — As 2015 gets under way, chain drug retailers in the United States and Canada are seeking ways to get the most out of pharmacy’s continued movement away from a dispensing orientation toward a service model focused on improved health outcomes. Chain drug industry executives say pharmacies are positioned to become integral health
January 5, 2015 by Jeffrey Woldt and Chain Drug Review
Alliance Boots, CEO, chief executive officer, drug chain, Greg Wasson, Jeffrey Woldt, retail pharmacy, Stefano Pessina, Walgreens
2015, Issue 01-05-2015, Opinion
When the history of Walgreen Co. is written, Greg Wasson, who last month announced that he would step down as chief executive officer of the drug chain upon completion of its merger with Alliance Boots, will be seen as one of the company’s most consequential leaders. A product of the Walgreens system who joined the
September 25, 2014 by Michael Wise, Vishal Bhandari, Kelsey Christian and Chain Drug Review
A.T. Kearney, Big Pharma, direct delivery, direct-to-consumer, health care delivery, Kelsey Christian, Michael Wise, pharmaceutical manufacturers, retail pharmacy, Vishal Bhandari
Issue 09-29-2014, Opinion
Are we seeing the first early “green shoots” of a new industry disruptor? Possibly. Big Pharma has started experimenting with direct-to-consumer models to fill prescriptions, effectively circumventing the retail pharmacy. Is the position of neighborhood pharmacies in today’s delivery system secure, or could the pharmacy suffer the same fate as the corner bookstore, replaced by
April 2, 2014 by Chain Drug Review
Duncan Mac Naughton, John Agwunobi, Labeed Diab, retail pharmacy, Walmart
Retail News
BENTONVILLE, Ark. — Labeed Diab has been appointed senior vice president and president of health and wellness at Walmart U.S. Walmart said Wednesday that Diab takes over that post from Dr. John Agwunobi, who is leaving the company after serving in that role since 2007. The move was announced in a company memo by Duncan